Arcoma AB (STO:ARCOMA)
Sweden · Delayed Price · Currency is SEK 8.52
-0.62 (-6.78%)
Jun 12, 2026, 2:56 PM CET
Arcoma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 127.06 | 130.8 | 156.81 | 163.02 | 125.05 | 117.13 | |
Revenue Growth (YoY) | -12.51% | -16.59% | -3.81% | 30.36% | 6.76% | -0.24% |
Cost of Revenue | 76.43 | 77.53 | 94.2 | 105.1 | 74.6 | 75.48 |
Gross Profit | 50.63 | 53.27 | 62.61 | 57.91 | 50.45 | 41.65 |
Selling, General & Admin | 39.01 | 39.07 | 42.79 | 45.25 | 42.87 | 44.6 |
Other Operating Expenses | 0.02 | 0.62 | -1.77 | -0.09 | -2.15 | -0.29 |
Operating Expenses | 46.04 | 47.04 | 48.96 | 53.25 | 47.32 | 50.44 |
Operating Income | 4.58 | 6.24 | 13.65 | 4.66 | 3.13 | -8.79 |
Interest Expense | -0.11 | -0.12 | -0.26 | -1.39 | -0.9 | -0.76 |
Interest & Investment Income | 0.27 | 0.19 | 0.12 | - | - | 0 |
Earnings From Equity Investments | - | - | -0 | - | - | - |
Currency Exchange Gain (Loss) | - | - | 0.25 | -0.14 | -0.1 | 0.64 |
Other Non Operating Income (Expenses) | -0 | -0 | - | 0 | -0 | - |
EBT Excluding Unusual Items | 4.75 | 6.31 | 13.77 | 3.13 | 2.12 | -8.91 |
Pretax Income | 4.75 | 6.31 | 13.77 | 3.13 | 2.12 | -8.91 |
Income Tax Expense | 0.95 | 1.28 | 2.59 | 0.57 | 0.22 | -1.44 |
Net Income | 3.8 | 5.03 | 11.18 | 2.56 | 1.9 | -7.47 |
Net Income to Common | 3.8 | 5.03 | 11.18 | 2.56 | 1.9 | -7.47 |
Net Income Growth | -60.57% | -55.01% | 336.00% | 34.80% | - | - |
Shares Outstanding (Basic) | 15 | 14 | 13 | 13 | 13 | 13 |
Shares Outstanding (Diluted) | 15 | 14 | 13 | 13 | 13 | 13 |
Shares Change (YoY) | 10.65% | 8.52% | - | 0.93% | 0.94% | 1.68% |
EPS (Basic) | 0.26 | 0.35 | 0.85 | 0.19 | 0.15 | -0.58 |
EPS (Diluted) | 0.26 | 0.35 | 0.85 | 0.19 | 0.15 | -0.58 |
EPS Growth | -64.36% | -58.54% | 336.00% | 33.56% | - | - |
Free Cash Flow | 20.91 | 18.51 | 18.84 | 19.16 | -0.19 | -2.62 |
Free Cash Flow Per Share | 1.43 | 1.29 | 1.43 | 1.45 | -0.01 | -0.20 |
Gross Margin | 39.85% | 40.73% | 39.93% | 35.53% | 40.34% | 35.55% |
Operating Margin | 3.61% | 4.77% | 8.71% | 2.86% | 2.50% | -7.51% |
Profit Margin | 2.99% | 3.85% | 7.13% | 1.57% | 1.52% | -6.38% |
Free Cash Flow Margin | 16.45% | 14.15% | 12.02% | 11.75% | -0.15% | -2.24% |
EBITDA | 4.48 | 6.46 | 14.57 | 6.25 | 4.78 | -7.3 |
EBITDA Margin | 3.52% | 4.94% | 9.29% | 3.83% | 3.82% | -6.23% |
D&A For EBITDA | -0.11 | 0.23 | 0.92 | 1.59 | 1.66 | 1.5 |
EBIT | 4.58 | 6.24 | 13.65 | 4.66 | 3.13 | -8.79 |
EBIT Margin | 3.61% | 4.77% | 8.71% | 2.86% | 2.50% | -7.51% |
Effective Tax Rate | 19.98% | 20.23% | 18.80% | 18.19% | 10.32% | - |
Revenue as Reported | 128.76 | 132.62 | 160.45 | 165.99 | 129.88 | 117.97 |